Analysis of risk factors of complications for totally implantable venous devices in patients undergoing chemotherapy: a prospective observational study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200058834

Enrollment

Unknown

Registered

2022-04-17

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

Port group:Place infusion port

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. > 18 years old; 2. Suffering from malignant tumor, planned to undergo chemotherapy; 3. Agree to place the infusion port and have signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Hypersensitivity to local anesthetics (such as lidocaine and/or ropivacaine) during the procedure; 2. Those with contraindications to infusion port placement, such as poor coagulation function (APTT prolongation for more than 4 seconds, platelet count 1.5), fever or sepsis.

Design outcomes

Primary

Measure	Time frame
Related complications;	—

Secondary

Measure	Time frame
Type of tumor;Grade of tumor;Location for catheter placement;Length of catheter stay;Preoperative coagulation;	—

Countries

China

Contacts

Public ContactFang Fang

Zhongshan Hospital Affiliated to Fudan University

jerryfang81@hotmail.com+86 13681972715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026